Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVOCART Inject Plus for Knee Cartilage Defects
NCT03319797Phase 3Completed
- Sponsor
- TETEC AG
- Start
- Oct 2017
- Primary completion
- Feb 2021
- Modality
- Hydrogel Systems, Cell Therapies
- Countries
- 5
01
Overview
A Phase 3 trial of NOVOCART Inject in Articular Cartilage Defect of the Knee, sponsored by TETEC AG. Started Oct 2017; status: completed.
02
Drugs
NOVOCART Inject
03
Conditions
Articular Cartilage Defect of the Knee
Beyond the preview
Go deeper on NCT03319797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03319797.